Pretransplant HbA1c Is a Useful Predictor for the Development of New-Onset Diabetes in Renal Transplant Recipients Receiving No or Low-Dose Erythropoietin

Aims. To evaluate the predictive power of pretransplant HbA1c for new-onset diabetes after transplantation (NODAT) in kidney transplant candidates, who had several predispositions for fluctuated HbA1c levels. Methods. We performed a retrospective study of 119 patients without diabetes who received k...

Descripción completa

Detalles Bibliográficos
Autores principales: Tokodai, Kazuaki, Amada, Noritoshi, Haga, Izumi, Nakamura, Atsushi, Kashiwadate, Toshiaki, Kawagishi, Naoki, Ohuchi, Noriaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216713/
https://www.ncbi.nlm.nih.gov/pubmed/25386190
http://dx.doi.org/10.1155/2014/436725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216713/
https://www.ncbi.nlm.nih.gov/pubmed/25386190
http://dx.doi.org/10.1155/2014/436725

Ejemplares similares